Logo image of 8GM.DE

GENERAL MOTORS CO (8GM.DE) Stock Fundamental Analysis

FRA:8GM - Deutsche Boerse Ag - US37045V1008 - Common Stock - Currency: EUR

46.37  -0.31 (-0.66%)

Fundamental Rating

4

8GM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 29 industry peers in the Automobiles industry. While 8GM is still in line with the averages on profitability rating, there are concerns on its financial health. 8GM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

8GM had positive earnings in the past year.
In the past year 8GM had a positive cash flow from operations.
Each year in the past 5 years 8GM has been profitable.
Each year in the past 5 years 8GM had a positive operating cash flow.
8GM.DE Yearly Net Income VS EBIT VS OCF VS FCF8GM.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

8GM has a Return On Assets of 2.57%. This is in the lower half of the industry: 8GM underperforms 62.96% of its industry peers.
8GM has a Return On Equity (11.40%) which is in line with its industry peers.
8GM's Return On Invested Capital of 6.71% is fine compared to the rest of the industry. 8GM outperforms 62.96% of its industry peers.
8GM had an Average Return On Invested Capital over the past 3 years of 5.60%. This is below the industry average of 8.71%.
The 3 year average ROIC (5.60%) for 8GM is below the current ROIC(6.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.57%
ROE 11.4%
ROIC 6.71%
ROA(3y)3.21%
ROA(5y)3.26%
ROE(3y)13.38%
ROE(5y)14.1%
ROIC(3y)5.6%
ROIC(5y)5.91%
8GM.DE Yearly ROA, ROE, ROIC8GM.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

8GM has a Profit Margin of 3.84%. This is comparable to the rest of the industry: 8GM outperforms 40.74% of its industry peers.
In the last couple of years the Profit Margin of 8GM has declined.
With a Operating Margin value of 7.98%, 8GM is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
8GM's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 13.02%, 8GM is doing worse than 88.89% of the companies in the same industry.
8GM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 3.84%
GM 13.02%
OM growth 3Y-15.76%
OM growth 5Y13.42%
PM growth 3Y-20.89%
PM growth 5Y-4.37%
GM growth 3Y-11.63%
GM growth 5Y4.44%
8GM.DE Yearly Profit, Operating, Gross Margins8GM.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

2

2. Health

2.1 Basic Checks

8GM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for 8GM has been reduced compared to 1 year ago.
8GM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 8GM is higher compared to a year ago.
8GM.DE Yearly Shares Outstanding8GM.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
8GM.DE Yearly Total Debt VS Total Assets8GM.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

8GM has an Altman-Z score of 1.31. This is a bad value and indicates that 8GM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 8GM (1.31) is worse than 62.96% of its industry peers.
8GM has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 8GM (1.43) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.88
WACC7.64%
8GM.DE Yearly LT Debt VS Equity VS FCF8GM.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

8GM has a Current Ratio of 1.13. This is a normal value and indicates that 8GM is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.13, 8GM perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
8GM has a Quick Ratio of 1.13. This is a bad value and indicates that 8GM is not financially healthy enough and could expect problems in meeting its short term obligations.
8GM has a better Quick ratio (0.98) than 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.98
8GM.DE Yearly Current Assets VS Current Liabilites8GM.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

8GM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.37%, which is quite impressive.
The Earnings Per Share has been growing by 19.68% on average over the past years. This is quite good.
The Revenue has grown by 9.08% in the past year. This is quite good.
8GM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.43% yearly.
EPS 1Y (TTM)30.37%
EPS 3Y14.2%
EPS 5Y19.68%
EPS Q2Q%54.84%
Revenue 1Y (TTM)9.08%
Revenue growth 3Y13.85%
Revenue growth 5Y6.43%
Sales Q2Q%11.01%

3.2 Future

8GM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.13% yearly.
Based on estimates for the next years, 8GM will show a small growth in Revenue. The Revenue will grow by 4.80% on average per year.
EPS Next Y5.85%
EPS Next 2Y3.34%
EPS Next 3Y-7.29%
EPS Next 5Y-0.13%
Revenue Next Year-0.92%
Revenue Next 2Y-0.32%
Revenue Next 3Y2.17%
Revenue Next 5Y4.8%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
8GM.DE Yearly Revenue VS Estimates8GM.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B 150B 200B 250B
8GM.DE Yearly EPS VS Estimates8GM.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.54 indicates a rather cheap valuation of 8GM.
Based on the Price/Earnings ratio, 8GM is valued cheaper than 92.59% of the companies in the same industry.
8GM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.47.
Based on the Price/Forward Earnings ratio of 4.29, the valuation of 8GM can be described as very cheap.
8GM's Price/Forward Earnings ratio is rather cheap when compared to the industry. 8GM is cheaper than 81.48% of the companies in the same industry.
8GM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.74.
Industry RankSector Rank
PE 4.54
Fwd PE 4.29
8GM.DE Price Earnings VS Forward Price Earnings8GM.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 8GM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.43
8GM.DE Per share data8GM.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as 8GM's earnings are expected to decrease with -7.29% in the coming years.
PEG (NY)0.78
PEG (5Y)0.23
EPS Next 2Y3.34%
EPS Next 3Y-7.29%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.97%, 8GM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.70, 8GM is paying slightly less dividend.
With a Dividend Yield of 0.97, 8GM pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

The dividend of 8GM decreases each year by -18.77%.
Dividend Growth(5Y)-18.77%
Div Incr Years2
Div Non Decr Years2
8GM.DE Yearly Dividends per share8GM.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

8GM pays out 9.08% of its income as dividend. This is a sustainable payout ratio.
The Dividend Rate of 8GM has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP9.08%
EPS Next 2Y3.34%
EPS Next 3Y-7.29%
8GM.DE Yearly Income VS Free CF VS Dividend8GM.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B -10B
8GM.DE Dividend Payout.8GM.DE Dividend Payout, showing the Payout Ratio.8GM.DE Dividend Payout.PayoutRetained Earnings

GENERAL MOTORS CO

FRA:8GM (2/5/2025, 4:37:34 PM)

46.37

-0.31 (-0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)N/A N/A
Inst Owners88.37%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap50.99B
Analysts74.74
Price Target58.01 (25.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.59
Dividend Growth(5Y)-18.77%
DP9.08%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.3%
Min EPS beat(2)-1.45%
Max EPS beat(2)18.05%
EPS beat(4)3
Avg EPS beat(4)10.8%
Min EPS beat(4)-1.45%
Max EPS beat(4)18.54%
EPS beat(8)7
Avg EPS beat(8)14.35%
EPS beat(12)10
Avg EPS beat(12)13.93%
EPS beat(16)13
Avg EPS beat(16)20.48%
Revenue beat(2)2
Avg Revenue beat(2)5.81%
Min Revenue beat(2)5.45%
Max Revenue beat(2)6.17%
Revenue beat(4)3
Avg Revenue beat(4)3.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)6.17%
Revenue beat(8)6
Avg Revenue beat(8)2.99%
Revenue beat(12)8
Avg Revenue beat(12)1.7%
Revenue beat(16)9
Avg Revenue beat(16)1.14%
PT rev (1m)0.02%
PT rev (3m)12.58%
EPS NQ rev (1m)-0.85%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)2.07%
EPS NY rev (3m)2.7%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)3.9%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 4.54
Fwd PE 4.29
P/S 0.28
P/FCF N/A
P/OCF 2.62
P/B 0.84
P/tB 0.9
EV/EBITDA 5.43
EPS(TTM)10.22
EY22.04%
EPS(NY)10.82
Fwd EY23.32%
FCF(TTM)-5.26
FCFYN/A
OCF(TTM)17.71
OCFY38.2%
SpS164.94
BVpS55.5
TBVpS51.5
PEG (NY)0.78
PEG (5Y)0.23
Profitability
Industry RankSector Rank
ROA 2.57%
ROE 11.4%
ROCE 8.15%
ROIC 6.71%
ROICexc 7.87%
ROICexgc 8.1%
OM 7.98%
PM (TTM) 3.84%
GM 13.02%
FCFM N/A
ROA(3y)3.21%
ROA(5y)3.26%
ROE(3y)13.38%
ROE(5y)14.1%
ROIC(3y)5.6%
ROIC(5y)5.91%
ROICexc(3y)6.66%
ROICexc(5y)7.09%
ROICexgc(3y)6.88%
ROICexgc(5y)7.34%
ROCE(3y)6.8%
ROCE(5y)7.18%
ROICexcg growth 3Y-7.41%
ROICexcg growth 5Y14.11%
ROICexc growth 3Y-7.2%
ROICexc growth 5Y14.47%
OM growth 3Y-15.76%
OM growth 5Y13.42%
PM growth 3Y-20.89%
PM growth 5Y-4.37%
GM growth 3Y-11.63%
GM growth 5Y4.44%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA 3.3
Cap/Depr 210.74%
Cap/Sales 13.93%
Interest Coverage 2.42
Cash Conversion 73.62%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.98
Altman-Z 1.31
F-Score7
WACC7.64%
ROIC/WACC0.88
Cap/Depr(3y)201.81%
Cap/Depr(5y)189.83%
Cap/Sales(3y)13.92%
Cap/Sales(5y)15.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.37%
EPS 3Y14.2%
EPS 5Y19.68%
EPS Q2Q%54.84%
EPS Next Y5.85%
EPS Next 2Y3.34%
EPS Next 3Y-7.29%
EPS Next 5Y-0.13%
Revenue 1Y (TTM)9.08%
Revenue growth 3Y13.85%
Revenue growth 5Y6.43%
Sales Q2Q%11.01%
Revenue Next Year-0.92%
Revenue Next 2Y-0.32%
Revenue Next 3Y2.17%
Revenue Next 5Y4.8%
EBIT growth 1Y45.62%
EBIT growth 3Y-4.09%
EBIT growth 5Y20.72%
EBIT Next Year25.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3.83%
OCF growth 3Y9.84%
OCF growth 5Y6.03%